Vincenzo Zaccone

Plain English
This research reviewed the effects of SGLT2 inhibitors, medications commonly used for managing diabetes, heart failure, and kidney disease. While these medications are generally safe, patients taking them may experience side effects, particularly genital infections (which occurred in around 6-7% of patients) and urinary tract infections, although results vary. Understanding these potential issues helps doctors manage their patients better and improve treatment outcomes. Who this helps: This benefits patients with diabetes, heart failure, and chronic kidney disease.

Plain English
This study looked at how blood vessels are affected in patients with systemic sclerosis (SSc), including those in the very early stages of the disease (VEDOSS) and those with primary Raynaud's phenomenon (PRP). Researchers found that 57% of VEDOSS patients and 91% of SSc patients had changes in small blood vessels, while 50% of VEDOSS and 52.9% of SSc patients showed issues with larger blood vessels, compared to just 21.4% in the PRP group. These results are important because they reveal that problems with larger blood vessels start early in systemic sclerosis and current risk assessments may not accurately reflect the actual vascular health of these patients. Who this helps: This helps patients with systemic sclerosis and their doctors by improving understanding of their vascular health.

Plain English
This study looked at how different treatment guidelines for acute heart failure (AHF) compare and how they can be used in emergency departments. The researchers identified five key issues, such as the best ways to deliver oxygen and diuretics and the role of certain medications, ultimately proposing the top recommendations for managing AHF effectively. This matters because finding the best approach can lead to better care for patients experiencing AHF in emergency settings. Who this helps: Emergency department doctors and their patients.

Plain English
This research paper focuses on systemic sclerosis (SSc), a disease that affects blood vessels, the immune system, and causes stiffening of tissues. The study finds that ongoing issues with blood vessel cells (endothelial dysfunction) are crucial in causing damage and changes associated with SSc, leading to serious problems like high blood pressure in the lungs and organ damage. Understanding this may change how SSc is treated and open up new treatment options. Who this helps: This benefits patients with systemic sclerosis and their doctors.

Plain English
This study looked at how common distal deep vein thrombosis (DDVT) is in patients admitted to internal medicine wards and what factors increase the risk of it getting worse. Among nearly 1,500 patients, 4% already had DDVT when they were admitted, and by the time of discharge, that number rose to 68 cases (including those whose condition worsened). The research found that being less mobile and having active cancer heightened the risk of DDVT spreading to more major veins, highlighting the need for routine ultrasound checks, especially for oncology patients and those with pneumonia. Who this helps: This helps patients in hospitals, particularly those with cancer and pneumonia, by ensuring early detection and treatment of blood clots.

Plain English
This research paper looks at new techniques and medications for treating pulmonary embolism (PE), a serious condition where blood clots block blood flow in the lungs. The study highlights that direct oral anticoagulants are a safe option for treating stable PE, with a low risk of bleeding, while advanced treatments like mechanical thrombectomy and catheter-directed thrombolysis show promise for more severe cases. Understanding these advancements is important because they can lead to better care and outcomes for patients with this life-threatening condition. Who this helps: Patients suffering from pulmonary embolism and healthcare providers managing their treatment.

Plain English
This study looked at two surgical methods for removing kidney tumors—one that involves clamping the renal artery (on-clamp) and one that does not (off-clamp). Researchers analyzed data from 333 surgeries and found that both methods had similar results in terms of complications, but the off-clamp method led to a small reduction in hemoglobin loss and kidney function decline, despite slightly more blood loss. These findings suggest that, while both techniques are effective, the off-clamp method may offer some advantages without compromising safety. Who this helps: Patients undergoing kidney cancer surgery.

Plain English
The AURELIO study examined the use of blood thinners to prevent blood clots in patients hospitalized for serious medical issues. Out of 2,371 patients, 18.6% received these medications upon admission. Notably, while high-risk patients (42.9%) were prescribed prophylaxis 33.4% of the time, only 7.6% of low-risk patients received it, highlighting gaps in treatment that could help reduce clot-related complications in the future. Who this helps: This benefits patients at risk of blood clots and healthcare providers seeking to improve patient care.

Plain English
This study looked at how the COVID-19 pandemic has affected the well-being of Italian doctors, focusing on their physical and mental health. Out of 228 surveyed physicians, 58.3% reported sleep problems, and 47.8% experienced mood swings, with younger doctors (residents) notably feeling more stressed and working longer hours. These findings highlight the significant impact of the pandemic on healthcare workers, emphasizing the need for further research and support. Who this helps: This research benefits doctors, especially younger physicians and healthcare systems aiming to improve support for their staff.

Plain English
This study looked at the prescribing patterns of blood pressure medications in over 5,600 older patients who were admitted to hospitals in Italy. It found that 31% of patients on minimum treatment (the recommended medications) at admission stopped using them by discharge, and this discontinuation was linked to higher risks of death and hospitalization. Keeping patients on these recommended blood pressure medications during their hospital stay helps improve their health outcomes after leaving the hospital. Who this helps: This helps older patients and their doctors by highlighting the importance of consistent hypertension treatment in hospitals.

Plain English
This study investigated the use of advanced 3D models created with artificial intelligence (AI) to help doctors plan complex kidney surgeries. Researchers successfully developed a high-accuracy 3D model for a 54-year-old woman with a kidney tumor, allowing for a smooth robotic surgery that lasted 85 minutes with no complications. This is important because it shows that AI can make surgical planning more effective and safe, potentially improving outcomes for patients undergoing similar procedures. Who this helps: This benefits patients needing kidney surgery and their surgeons.

Plain English
This study examined the effects of low-dose aspirin on survival rates in hospitalized COVID-19 patients suffering from pneumonia. Researchers analyzed data from 3,044 patients and found that whether patients were on low-dose aspirin or not did not significantly affect mortality rates (35.7% for those on aspirin versus 33.7% for those not on it). The key factors that influenced death were age, oxygen levels, and the time between the onset of symptoms and hospitalization. Who this helps: This research helps doctors understand the impact of low-dose aspirin on COVID-19 patients and informs treatment decisions.

Plain English
This study focused on the risks of blood clots in patients who need long-term nutrition through a tube placed in their veins, known as parenteral nutrition (PN). The researchers found that catheter-related venous thrombosis (CRT) is a significant problem because it can cause patients to lose their access to nutrition and lead to treatment failure. Despite there being limited research on the topic, the Italian Society of Clinical Nutrition and Metabolism gathered expert opinions to create practical recommendations for preventing and treating these clots, emphasizing the need for better guidelines. Who this helps: This benefits patients receiving long-term parenteral nutrition and their healthcare providers.

Plain English
This study looked at how COVID-19 affects blood vessel health, particularly in people who continue to experience symptoms long after their initial infection, known as long COVID. Researchers found that COVID-19 can damage the blood vessels, leading to heart-related issues even after recovery, with mechanisms like inflammation and blood clots contributing to these problems. This is important because understanding these effects can help identify and treat cardiovascular issues in long COVID patients. Who this helps: This helps patients recovering from COVID-19 who are experiencing cardiovascular problems.

Plain English
This study looked at how pre-existing health issues, measured by the Charlson Comorbidity Index, relate to the development of long-lasting symptoms after COVID-19, known as post-COVID syndrome. Researchers examined 3,636 patients and found that those with any comorbidities had nearly three times the risk of experiencing post-COVID syndrome, and those with more serious health issues (a CCI score of 4 or more) had about six times the risk. Understanding this connection is important because it helps identify which patients might be more susceptible to prolonged health problems after COVID-19. Who this helps: This information benefits doctors and healthcare providers by guiding them in monitoring and supporting patients with existing health conditions who are recovering from COVID-19.

Plain English
This study looked at nearly 1,800 patients who had COVID-19 to see how their heart health was related to how severely they got sick and whether they developed lingering health issues afterward. It found that patients with a high risk for heart problems were more likely to be hospitalized, experience severe symptoms, and suffer from post-COVID-19 syndrome three months later. This is important because it shows that managing heart health may be crucial for COVID-19 patients to prevent long-term complications. Who this helps: This helps patients and doctors by providing insight into the risks associated with COVID-19 and the importance of monitoring heart health.

Plain English
This study looked at 254 patients with intermediate-risk pulmonary embolism to find out if echocardiography could predict who might die within 90 days. The results showed that patients who did not survive had smaller heart volumes and lower blood flow output compared to those who survived. Key predictors of death included enlarged right atria, certain blood pressure ratios, and specific measures of heart function, which were more reliable than CT scans or blood tests in forecasting patient outcomes. Who this helps: This helps doctors identify at-risk patients more effectively.

Plain English
This research paper looked at the connections between Alzheimer's disease, problems with blood vessels in the brain, and factors that increase the risk of vascular issues, like high blood pressure and diabetes. The researchers found that these conditions share common pathways that could lead to the development and worsening of Alzheimer's. Addressing these vascular risk factors early may help lower the chances of developing Alzheimer's and delay cognitive decline. Who this helps: This benefits patients at risk for Alzheimer's, their families, and healthcare providers.

Plain English
This study looked at how well a specific heart test called TAPSE/PASp helps predict in-hospital death in patients with acute heart failure. Among 439 patients, those with normal TAPSE/PASp had much higher survival rates, with 100% surviving in the top risk categories, compared to significantly lower rates for those with abnormal tests (as low as 43.4%). This is important because it allows doctors to better assess the risk of death and make more informed decisions about patient care. Who this helps: This helps doctors and patients with acute heart failure by improving death risk assessments.

Plain English
This study looked at how well the Emergency Heart failure Mortality Risk Grade (EHMRG) predicts the likelihood of death within a week for elderly patients with acute heart failure (AHF) in Italian hospitals. Among 439 patients, 45 (10.3%) died during their hospital stay, with death rates increasing based on EHMRG scores—from 0% in the lowest risk category to 7.7% in a higher category. Understanding this risk helps hospitals treat elderly patients more effectively and could improve their chances of survival. Who this helps: This benefits elderly patients with acute heart failure and their healthcare providers by offering a better way to assess their risk.

Plain English
This study looked at older patients admitted to the hospital with acute heart failure and examined how different chronic health issues (comorbidities) grouped together and affected their risk of dying while in the hospital. Out of 459 patients, 12% (55 patients) died during their hospital stay. The researchers found that specific groups of comorbidities were better at predicting who was likely to die than a standard health measure called the Charlson comorbidity index. Who this helps: This research benefits doctors treating elderly patients with heart failure by providing them with better tools to assess risk and improve care strategies.

Plain English
This study looked at how COVID-19 affects the blood vessels of patients three months after they recover from the virus. It found that 78.3% of patients who were hospitalized had problems with their blood vessel function, compared to only 21.7% of those who received care at home, highlighting a clear link between the severity of COVID-19 and blood vessel health. Understanding these effects is important because it may help identify patients at higher risk for future heart or lung problems. Who this helps: This information benefits patients recovering from COVID-19, especially those who were hospitalized.

Plain English
This study looked at elderly patients with suspected infections who were admitted to medical units, focusing on a new scoring system called SOFA-T. Researchers found that measuring troponin I levels, which indicate heart injury, helped identify patients at higher risk of dying in the hospital; specifically, those with troponin I levels above 0.31 ng/ml had over 80% greater odds of in-hospital death. This is important because it suggests that combining troponin I with existing scoring systems can better predict outcomes for these vulnerable patients. Who this helps: This benefits elderly patients admitted for suspected infections and their healthcare providers.

Plain English
This study looked at the connection between chronic respiratory diseases, like asthma and COPD, and neurodegenerative disorders, such as Alzheimer's disease, especially in older people. Researchers found that many patients have both types of conditions, which makes their health care more complicated and affects treatment options. Understanding these connections is important because it can help doctors provide better care for patients dealing with both issues. Who this helps: This helps patients with chronic respiratory and neurodegenerative diseases and their doctors.

Plain English
This study looked at how well echocardiograms can identify pulmonary embolism (a blockage in the lungs) in patients who are stable and not in shock. The researchers reviewed ten studies and found that while echocardiograms showed high specificity (meaning they could correctly identify patients who do have the condition), they had low sensitivity (meaning some patients with the condition could be missed). This means that signs of right ventricle overload seen on echocardiograms should only guide doctors in high-risk patients and shouldn't change treatment for those at low to moderate risk. Who this helps: This helps doctors in emergency departments make better decisions for patients at risk for pulmonary embolism.

Plain English
This study focused on critically ill patients with atrial fibrillation, looking to identify risk factors for serious health issues, like in-hospital death, stroke, and major bleeding. Researchers developed machine learning models that accurately predicted these risks, with very high accuracy ratings: 97.4% for death or ICU transfer, 93.1% for stroke, and 93.0% for major bleeding. These findings are important because they can help doctors better assess patient risks and choose more effective treatments. Who this helps: This helps doctors and critically ill patients with atrial fibrillation.

Plain English
This study looked at how two specific tests, Delta-Procalcitonin (Delta-PCT) and vitamin D levels, can help predict whether patients with sepsis in internal medicine will survive. Researchers found that patients with a significant drop in Delta-PCT levels after 48 to 96 hours had a much lower risk of dying in the next two to three months—only 0.12 times the risk if their levels dropped by more than 50%. Additionally, patients with severe vitamin D deficiency had nearly four times the risk of dying within 28 days compared to those with sufficient levels. Who this helps: This information is valuable for doctors treating hospitalized patients with sepsis, allowing them to assess the risk of mortality more effectively.

Plain English
This study looked at procalcitonin (aPCT), a marker for bacterial infections, in critically ill patients to see how well it predicts patient outcomes, regardless of whether they had an infection. Out of 1,063 patients, those with higher aPCT levels were more likely to face serious issues, such as death or needing to be transferred to the ICU—450 patients experienced these outcomes. This finding is important because aPCT can provide helpful information about a patient’s risk of rapid decline, aiding doctors in making better treatment decisions. Who this helps: This helps doctors in hospitals treat critically ill patients more effectively.

Plain English
This study examined how patients with a history of atrial fibrillation (AF) do when admitted to a stepdown care unit, focusing on serious outcomes like death or needing to be transferred back to intensive care. Out of 1,430 patients studied, 194 (about 14%) experienced these serious outcomes. Key factors related to worse outcomes included older age and specific conditions like cardiogenic and septic shock, while the use of blood-thinning medications reduced the risk of stroke but increased the chances of severe adverse effects. Who this helps: This research helps doctors better understand the risks for critically ill patients with AF to improve their care.

Plain English
This study looked at the treatment of patients with vascular dementia who also have atrial fibrillation, a condition that increases the risk of strokes. Among 193 patients with both conditions, it was found that 99.5% should have received anticoagulant medication to reduce stroke risk, but only 69.9% actually got the proper treatment. The study found that 24.3% of patients with vascular dementia experienced strokes while hospitalized, compared to just 0.8% of patients without dementia, showing that these patients are not receiving the care they need despite being at much higher risk. Who this helps: This helps patients with vascular dementia and atrial fibrillation by highlighting the need for better treatment practices.

Plain English
This study looked at how well two medical scoring systems, SOFA and qSOFA, can predict in-hospital death for elderly patients with suspected infections who are placed in less intensive care settings. Out of 390 patients examined, 144 (about 37%) died in the hospital, and both scores showed a connection to this outcome, but their accuracy was not very strong, scoring around 0.68. This matters because it highlights that although these scores can help identify patients who might need more care, they are not very reliable. Who this helps: This research helps doctors assess the risks faced by elderly patients in hospitals.

Plain English
This study looked at patients newly diagnosed with polymyalgia rheumatica (PMR) to understand how their blood vessels function before and after starting steroid treatment. The researchers found that these patients had poorer blood vessel function compared to healthy individuals, with a significant difference that persisted for at least six months even though their overall health improved after one month of steroids. This is important because it shows that PMR leads to ongoing blood vessel issues, which could increase the risk of heart problems over time. Who this helps: This information benefits patients with PMR and their doctors by highlighting the need for ongoing monitoring of heart health during treatment.

Plain English
This study focused on how the MEDS score and vitamin D levels are linked to survival rates in patients with sepsis, a life-threatening condition. Researchers found that out of 88 septic patients aged around 75, about 26% died within 28 days and 38% within 90 days. Higher MEDS scores were associated with increased mortality, and low vitamin D levels predicted a worse outcome, making values below 7 ng/ml particularly concerning. Who this helps: This research benefits doctors and healthcare providers by identifying which patients are at higher risk of dying from sepsis, allowing for better care strategies.

Plain English
This study looked at how sepsis, a severe condition caused by infections, is being managed in Internal Medicine wards, especially since more patients are being treated there instead of Intensive Care Units. Researchers found that adherence to treatment guidelines is improving patient outcomes, with more consistent use of tools like the SOFA score for identifying sepsis, and methods like ultrasound and lab tests to guide treatment. This matters because better management of sepsis can significantly reduce complications and deaths, which is crucial as the number of patients with this condition continues to rise. Who this helps: This helps patients with sepsis and the doctors caring for them.

Plain English
This study introduced a new scoring system called the ULLA score to evaluate the health of arteries in the legs for people with peripheral arterial disease (PAD). Researchers looked at 320 individuals and found that this new score is strongly linked to known cardiovascular risk factors, like age, smoking, and diabetes. Understanding these connections helps doctors assess PAD more accurately, especially in its early stages, which can lead to better management of cardiovascular health. Who this helps: This helps patients with peripheral arterial disease and their doctors.

Plain English
This study looked at infections that occur in people with weakened immune systems when they have catheters inserted. It found that specific germs, known as opportunistic pathogens, can cling to these catheters and cause severe infections, which can be deadly. The research highlights that two patients with complex health issues recovered when treated with a method called antibiotic lock-therapy, which involves using antibiotics to prevent infection in the catheter. Who this helps: This helps patients with weakened immune systems and their doctors in managing catheter-related infections.

Plain English
This study focused on a type of cell called endothelial progenitor cells (EPCs), which are important for creating new blood vessels in the body. The researchers found that EPCs are not a single type of cell but rather a mix of different cell types that work together to support blood vessel development. Understanding the true identity of these cells is crucial because it can improve how stem cell therapies are used in medical treatments. Who this helps: This benefits patients needing new treatments for conditions related to blood vessel issues.

Plain English
This study looked at how too much iron in the body can lead to serious health issues, particularly affecting the liver. Researchers found that conditions like hemochromatosis and various liver diseases can cause harmful iron buildup, which can result in liver damage and even cancer. Understanding these processes is crucial for preventing and treating iron overload-related health problems. Who this helps: This helps patients with iron-related disorders and health care providers managing their care.

Plain English
This study looked at how G-CSF, a growth factor, affects patients with ischemic heart failure who cannot undergo surgery. The researchers found that after treatment, patients showed significant improvements in heart failure symptoms, with their condition rating improving from an average of class 3 to class 2 on a standard scale, and overall quality of life scores increasing from 33 to 64 out of 100. These results suggest that G-CSF may help relieve symptoms and improve heart function in patients who have few other treatment options. Who this helps: This helps patients with ischemic heart failure who are not candidates for surgical procedures.

Plain English
This study looked at whether eating a cold dessert called "Gran Soleil," with or without added digestive herbs, helps people with functional dyspepsia, a condition that causes stomach discomfort. Thirty participants reported their symptoms, and it was found that eating "Gran Soleil" without herbs reduced their discomfort and the number of symptoms experienced; adding the herbs made these benefits even stronger. This matters because it offers a simple dietary option to help alleviate stomach pain in people suffering from this common issue. Who this helps: This helps patients with functional dyspepsia.

Plain English
This research paper looks at how certain factors and medications affect the movement of endothelial progenitor cells (EPCs), which are important for heart and blood vessel health. The findings indicate that the number of EPCs in the blood can predict the risk of heart problems and changes in the heart after a heart attack. Understanding EPCs better could improve the treatment of cardiovascular diseases. Who this helps: This helps patients with heart conditions and their doctors.

Plain English
This study explored the connection between celiac disease (CD) and skin issues, highlighting how patients with CD often experience skin problems due to the condition. It reviewed various skin diseases linked to CD and suggested that these issues might arise from problems with nutrient absorption and immune system changes. Understanding this relationship is important because it can help identify celiac disease in patients who have unexplained skin conditions, leading to better diagnosis and treatment. Who this helps: This benefits patients with unexplained skin issues and their doctors.

Plain English
This study looked at how two different doses of statins affect special cells called endothelial progenitor cells (EPCs) and heart function in patients who had a heart attack and received treatment to open blocked arteries. Researchers found that patients who received the higher dose of statin after their heart attack had more EPCs four months later (7.59 vs 3.04), which indicates better potential for heart repair, but this didn’t improve heart function measurements. This is important because while higher doses of statins may help in regenerating these protective cells, it did not lead to better heart performance. Who this helps: Patients recovering from heart attacks.